Detalles de la búsqueda
1.
Genetic and Functional Drivers of Diffuse Large B Cell Lymphoma.
Cell
; 171(2): 481-494.e15, 2017 Oct 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-28985567
2.
High karyotypic complexity is an independent prognostic factor in patients with CLL treated with venetoclax combinations.
Blood
; 142(5): 446-459, 2023 08 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-37172204
3.
Prior exposure to chemotherapy does not reduce the in vitro maturation potential of oocytes obtained from ovarian cortex in cancer patients.
Hum Reprod
; 38(9): 1705-1713, 2023 09 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-37414543
4.
A retrospective study of 222 patients with newly diagnosed primary central nervous system lymphoma-Outcomes indicative for improved survival overtime.
Hematol Oncol
; 41(5): 838-847, 2023 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-37403752
5.
Rituximab versus obinutuzumab-based first-line chemoimmunotherapy for follicular lymphoma-a real-world multicenter retrospective cohort study.
Ann Hematol
; 102(8): 2127-2136, 2023 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-37335322
6.
Risk factors and outcomes of COVID-19 in adult patients with hematological malignancies: A single-center study showing lower than expected rates of hospitalization and mortality.
Eur J Haematol
; 111(1): 135-145, 2023 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-37096337
7.
Safety and efficacy of the BNT162b mRNA COVID-19 vaccine in patients with chronic lymphocytic leukemia.
Haematologica
; 107(3): 625-634, 2022 03 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-34320789
8.
Polatuzumab-based regimen or CAR T cell for patients with refractory/relapsed DLBCL-a matched cohort analysis.
Ann Hematol
; 101(4): 755-762, 2022 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-35083525
9.
Pembrolizumab versus brentuximab vedotin in relapsed or refractory classical Hodgkin lymphoma (KEYNOTE-204): an interim analysis of a multicentre, randomised, open-label, phase 3 study.
Lancet Oncol
; 22(4): 512-524, 2021 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-33721562
10.
Evaluation of cerebrospinal clonal gene rearrangement in newly diagnosed non-Hodgkin's lymphoma patients.
Ann Hematol
; 98(11): 2561-2567, 2019 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-31515574
11.
Characteristics, management and outcome of DLBCL patients, presenting with simultaneous systemic and CNS disease at diagnosis: A retrospective multicenter study.
Am J Hematol
; 94(9): 992-1001, 2019 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-31211434
12.
Romidepsin-Bendamustine Combination for Relapsed/Refractory T Cell Lymphoma.
Acta Haematol
; 141(4): 216-221, 2019.
Artículo
en Inglés
| MEDLINE | ID: mdl-30943470
13.
Persistently low lymphocyte counts after FCR therapy for chronic lymphocytic leukemia are associated with longer overall survival.
Hematol Oncol
; 36(1): 128-135, 2018 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-28639416
14.
Outcomes of second-line treatment after fludarabine cyclophosphamide and rituximab in patients with chronic lymphocytic leukemia outside clinical trials.
Eur J Haematol
; 101(3): 399-406, 2018 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-29949186
15.
Daratumumab resistance is frequent in advanced-stage multiple myeloma patients irrespective of CD38 expression and is related to dismal prognosis.
Eur J Haematol
; 100(5): 494-501, 2018 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-29453884
16.
Efficacy of front-line ibrutinib versus fludarabine, cyclophosphamide, and rituximab in patients with chronic lymphocytic leukemia: A retrospective multicenter "Real-World" study.
Am J Hematol
; 98(2): E24-E27, 2023 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-36349541
17.
Modification of initial therapy in early and advanced Hodgkin lymphoma, based on interim PET/CT is beneficial: a prospective multicentre trial of 355 patients.
Br J Haematol
; 178(5): 709-718, 2017 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-28589704
18.
Progressive refractory light chain amyloidosis and multiple myeloma patients are responsive to the addition of clarithromycin to IMiD based therapy.
Am J Hematol
; 92(2): 131-135, 2017 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-27804150
19.
Deformability of transfused red blood cells is a potent determinant of transfusion-induced change in recipient's blood flow.
Microcirculation
; 23(7): 479-486, 2016 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-27406436
20.
Azacitidine-lenalidomide (ViLen) combination yields a high response rate in higher risk myelodysplastic syndromes (MDS)-ViLen-01 protocol.
Ann Hematol
; 95(11): 1811-8, 2016 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-27546027